CSN Login
Members Online: 8

Trial of Avastin and Ipabexilone

thaxter's picture
thaxter
Posts: 72
Joined: Jan 2014

IL-2 has been my first line of treatment for my lung mets discovered in January after Sept nephrectomy.  I did talk to National Cancer Institute about kidney cancer trials a few months ago and they gave a link to this study.

A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma

http://clinicalstudies.info.nih.gov/detail/A_2009-C-0057.html

I will find out Monday whether my initial rounds of IL2 worked and if not I want to ask the oncologist about the above study.  Does anyone have knowledge/experience with either of these drugs?

Since I am only two hours from NCI and treatment there is free this seems like something I might look into.  Seems like I meet the qualifications although I'm not sure about all the blood test results for liver, kidney, etc. 

 

 

 

 

NanoSecond's picture
NanoSecond
Posts: 532
Joined: Oct 2012

The first drug is a monoclonal antibody that blocks angiogenesis (i.e the formation of new blood vessels).  In that regard it is similar to Sutent, Inlyta, and Votrient.  However, it is not a TKI (Tyrosine Kinase Inhibitor) and so may not be as effective.

I believe the second drug is more along the lines of traditional chemotherapy.  If I am right then it may require faster dividing cells (i.e. more aggressive) form of RCC to be effective.

Before you jump on this clinical trial I highly recommend you research to see if there are any immune-based trials you could qualify for.  These include those that are testing any of the various anti-PD1; anti-PDL1; anti-LAG3; etc. drugs.

I live only 10 miles from the NIH/NCI and am enrolled in a clinical trial of an anti-PDL1 drug.  I have been extremely impressed by the entire faciilty and all the doctors and nurses that I have had the pleasure of dealing with.

thaxter's picture
thaxter
Posts: 72
Joined: Jan 2014

I think you are right about the second drug--the abstract says it is like Taxol which I believe is a chemo drug used for breast cancer, etc. I did have significant growth in my lung mets between 1/9 and 2/24.  I don't know if that would be called agressive, but it was disconcerting to read the report.

 

When I talked to NCI a few months ago this trial was the one they emailed me about.  When I search using keywords like "renal" or "renal cancer" I don't see any open immune based trials open at NCI.  I have a good friend who was treated at NCI--they did a laparoscopic full nephrectomy of a 10 cm tumor--and he is always urging me to find treatment there.  Having grown up in the DC area and lived there for nearly 60 years I would be glad to find some program there.  I do have confidence in my current oncologist, Dr. Weiss at UVa's Emily Couric Cancer Center and was pleased to find out that I was going to get IL-2 at a facility that does several patients every week. 

Actually if I get good news on Monday it will mean another round of IL-2 probably in June, I don't know what sort of treatment Dr. Weiss will recommend if another round of IL-2 is not called for, but I wanted to get information on the NCI trial so I can discuss this with him.

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2014 © Cancer Survivors Network